Inhalable dry powder antibiotic may reduce TB treatment timeNovember 17th, 2010 - 2:52 pm ICT by ANI
Washington, Nov 17 (ANI): New research has indicated that an inhalable dry powder antibiotic that when used alone or with current treatments may significantly reduce treatment for tuberculosis (TB) and multi-drug resistant TB.
Lead researcher J’aime Manion and her colleagues from the University of Colorado developed the inhalable dry powder, comprised of fine particles of antibiotics. These particles are targeted to the deep lung where TB enters in early stages of infection. The goal of this method is to distribute a larger fraction of antibiotic to protected TB lesions that are difficult to access by current treatments.
“Combining this novel treatment with more traditional methods may increase the targeted dose to the lung airspace and tissue, potentially reducing treatment time and systemic side effects,” said Manion.
“As an inhalable powder, it eliminates the storage, disposal and contamination challenges that developing countries face with a needle delivery method.”
The research will be presented at the 2010 International Pharmaceutical Federation (FIP) Pharmaceutical Sciences World Congress (PSWC) in association with the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition. (ANI)
- Jab-free HPV vaccine 'more effective, cheaper' for developing nations - Nov 18, 2010
- New findings on drug tolerance could help cure TB faster - Mar 04, 2011
- Measles vaccine inhaler shows promise - Sep 29, 2009
- Pharma bigwigs join hands for new TB drug - Jun 27, 2012
- 'Time to scale up work on TB control' - Jan 24, 2012
- Indian trial for inhalable measles vaccine offers hope for other diseases - May 06, 2010
- New advance made in TB research - Jul 30, 2010
- Tuberculosis enzyme responsible for lung destruction identified - Apr 26, 2011
- WHO calls for dealing with multi-drug resistant microbes - Apr 07, 2011
- 90-minute TB test not a game changer for India - Aug 29, 2011
- TB-drugome may pave way for anti-TB drug discovery - Nov 09, 2010
- 'Urgent measures needed to control drug resistant TB' - Mar 23, 2012
- Faster body metabolism renders TB drugs ineffective - Jan 04, 2012
- Gonorrhea cure gets tough as bug grows drug resistant - Nov 08, 2011
- Poor people are most hard-hit by TB, COPD and tobacco - Nov 06, 2010
Tags: airspace, antibiotic, delivery method, drug resistant tb, fip, manion, multi drug resistant tb, novel treatment, pharmaceutical federation, pharmaceutical sciences, pharmaceutical scientists, pswc, storage disposal, systemic side effects, tb treatment, time washington, treatment time, tuberculosis tb, university of colorado, world congress